This is the authors' abstract. We don't add key points for this paper.
This commentary explores whether there is epistemic injustice in global antimicrobial resistance (AMR) research - who sets priorities, who produces knowledge, and which types of knowledge are valued. We argue that epistemic injustice may have created blind spots in policy. Addressing this requires a commitment to diversity, equity, and inclusion.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Cheah et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: